Analysis for APH
- 📈 Growth — 25/30
- 💰 Profitability — 17/20
- 🏦 Financial Health — 14/20
- 💵 Valuation — 16/20
- ⚠️ Risk — 7/10
Summary:
📈 Growth & Financial Trajectory
Over the eight quarters, AMPHENOL's Revenues rose from roughly $4.32B in 2024 Q2 to about $7.62B in 2026 Q1, a ~76% gain. Net income fluctuated but stayed solid, moving from ~$0.75B in 2025 Q1 to around $1.26B in late-2025, then easing to about $0.94B in 2026 Q1. The revenue run-rate shows a steady uptrend, with accelerating growth in 2025 and a continued expansion into 2026.
💰 Margins & Cash Flow
Gross Margin has trended in the mid-30s to low-40s percent, with 2025 quarters around the high 30s to low 40s and Q1 2026 near 37%. Operating Margin runs in the 20-25% range, supported by stable SG&A. Net cash flow from operating activities remained positive in most quarters, but financing activities created large swings (notably a strong cash inflow in late 2025 and a significant outflow in Q1 2026), resulting in volatile total cash flow.
🛡️ Balance Sheet & Liquidity
Total assets sit around $36B–$42B across recent quarters, with liabilities about $28B and equity near $14B in early 2026. Cash balances are healthy (multi-billon), and liquidity remains robust despite elevated debt-like obligations; no material near-term maturities flagged.
⚠️ Key Drivers & Risks
- Drivers: AI/Data Center component demand; diversified industrial/end-markets.
- Risks: Cyclicality in electronics supply chains; margin pressure from cost inflation and currency exposure; cash-flow volatility tied to financing activity.